Brian Pla is a cell therapy and exosome expert advancing the intersection of regenerative science and aesthetic innovation. As Founder & President of Exora™ Skin Labs, he leads the evolution of JuveXO® and its signature ingredient, ExoCM®, with a vision to redefine premium skincare through advances in cellular signaling and conditioned exosome technology.
His career spans finance, precision medicine, and cellular therapies. In 2017, Brian founded Gentera Centers for Precision Medicine and Plastic Surgery in Coral Gables, Florida, establishing a presence in personalized and cellular medicine. He also leads ReHealth in Cancún, Mexico, where his team develops advanced & US-licensed cell therapy applications.
Through years of experience in cell-based therapies, Brian has developed expertise in cellular signaling, secretomes, and exosomes, with a particular emphasis on their applications in aesthetic medicine. In collaboration with TheBioBox, he helped bring JuveXO® to market in 2019, advancing the application of exosome science within professional aesthetics.
Dr. Gonzalez earned his Ph.D. and B.S. from the University of California, Irvine, where his research explored the interactions of the immune system following spinal cord injury. A distinguished expert in stem cell biology and regenerative medicine, he has devoted his career to guiding cell-based innovation from scientific discovery to clinical application.
As a leader in cellular therapeutics, Dr. Gonzalez has directed the development of stem cell applications for a range of diseases and traumatic conditions, overseen multiple investigational new drug applications built on patented stem cell technologies, and advanced the clinical development of immune-based therapies.
Today, he brings this depth of expertise to the art of skin longevity. Dr. Gonzalez led the development of ExoCM®, a proprietary conditioned exosome formulation and the signature ingredient at the heart of our premium skincare. Drawing on the body’s own language of cellular signaling, ExoCM® represents a new standard in skin rejuvenation, where rigorous science meets refined luxury.
A published researcher and recognized lecturer through the American Academy of Anti-Aging, Dr. Gonzalez is highly regarded throughout the regenerative medicine community. His work reflects a singular commitment to translating scientific excellence into transformative results for skin health and longevity.
Damon Sementilli serves as Vice President of Operations at JuveXO®, where he leads operational strategy, supply-chain execution, and commercial scalability across the company’s advanced regenerative and exosome-derived platforms. Over the course of nearly two decades, Damon has built deep expertise at the intersection of biotech, functional ingredients, fragrance, and prestige beauty. He previously served as Vice President of a fragrance and functional ingredient company supporting the personal care and beauty industries, where he worked with hundreds of global and emerging brands on ingredient-led marketing campaigns and thousands of perfumery submissions across fine fragrance and personal care briefs. Throughout his career, Damon has collaborated with leading multinational organizations including Procter & Gamble, L’Oréal, and Unilever, as well as numerous high-growth startups, helping translate technical innovation into commercially successful products. He is also the Founder and former President of Beauty Brand Alchemist, a consultancy focused on brand strategy, ingredient storytelling, and go-to-market execution for beauty and wellness brands. Damon holds a business degree from the University of Louisville and is a Lean Six Sigma Black Belt, bringing a disciplined, data-driven approach to operational excellence and continuous improvement. At JuveXO®, Damon applies his combined operational, scientific, and commercial experience to scale cutting-edge technologies with rigor, compliance, and long-term brand value.
Sylvia, VP of Growth and Strategy at Exora™ Skin Labs, is a seasoned leader with a proven track record spanning the U.S., Latin America, and Europe. With over two decades of experience in Marketing, Business Development, and Strategic Ideation, she excels in driving transformation across diverse sectors.
Sylvia’s focus is to solidify Exora™ Skin Labs’ brand as the leader in cell-derived beauty and launch new products that will undoubtedly transform the aesthetics landscape. Previously serving as Director of Business Acquisition and Digital Transformation at Abbott Laboratories for the Latin American Region, Sylvia played a pivotal role in shaping strategies for growth. In 2020, she also co-founded a healthcare start-up focused on COVID Testing and spearheaded numerous global partnerships. Sylvia holds an Executive MBA from Northwestern’s Kellogg School of Business Management and a Bachelor’s in Communications from the University of Miami.